Overview

Scotoma Reduction in AMD Patients Treated With Ranibizumab

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This is a trial aimed at patients with advanced wet macular degeneration and macular scarring treated wiht intravitreal injections of Lucentis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Retina Research Foundation
Treatments:
Ranibizumab